CNCE - Concert Pharmaceuticals raises $66.4M through share offering and warrant exercise

Concert Pharmaceuticals (NASDAQ:CNCE) has raised $66.4M in gross proceeds through its previously announced underwritten public offering of 10M shares and exercise of warrants. Each share was offered at $4.75. Aggregate gross proceeds to Concert from this offering were $47.5M. The pharma firm also received $18.9M upon the exercise of tranche 1 warrants to purchase 3,981 shares of Series X1 Preferred Stock issued to BVF Partners and RA Capital Management in Nov 2021. Shares have slipped ~2% in extended trading

For further details see:

Concert Pharmaceuticals raises $66.4M through share offering and warrant exercise